University of Alabama at Birmingham researchers report additional preclinical evidence of the potency of a single-dose, intranasal COVID-19 vaccine candidate—AdCOVID—that was created by Altimmune Inc., a Maryland-based clinical-stage biopharmaceutical company. The UAB researchers, led by Fran Lund, Ph.D., in collaboration with Altimmune, have found that a single intranasal dose provided sterilizing immunity in the lungs […]